FBLG (FibroBiologics) Net Income (Continuing Operations) : $-7.67 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. FibroBiologics's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was $-4.97 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was $-7.67 Mil.

FibroBiologics Net Income (Continuing Operations) Historical Data

The historical data trend for FibroBiologics's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Net Income (Continuing Operations) Chart

FibroBiologics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Net Income (Continuing Operations)

-1.58

-5.12

-16.49

-11.16

FibroBiologics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income (Continuing Operations)	Get a 7-Day Free Trial							-8.46	0.90	-0.50	-3.10	-4.97

FibroBiologics Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.67 Mil.

FibroBiologics (NAS:FBLG) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

FibroBiologics Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

SG0:Germany

Address

455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598

Website

https://www.fibrobiologics.com

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.